D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Robert Half
RHI
$3.61B
| $1.11M | ﹤0.01% |
+19,184
| New | +$1.1M |
|
2377
Estee Lauder
EL
$29B
| $1.11M | ﹤0.01% |
7,386
-128,507
| -95% | -$17.8M |
|
2378
CALL
HCA Healthcare
HCA
$84.8B
| $1.11M | ﹤0.01% |
+11,400
| New | +$1.11M |
|
|
PSB
2379
DELISTED
PS Business Parks, Inc.
PSB
| $1.1M | ﹤0.01% |
9,771
+7,309
| +297% | +$842K |
|
|
REN
2380
DELISTED
Resolute Energy Corporaton
REN
| $1.1M | ﹤0.01% |
+31,784
| New | +$1.08M |
|
2381
CALL
Leidos
LDOS
$14.1B
| $1.1M | ﹤0.01% |
16,800
-6,400
| -28% | -$422K |
|
|
LNW
2382
DELISTED
Light & Wonder
LNW
| $1.1M | ﹤0.01% |
+26,414
| New | +$1.24M |
|
2383
Teleflex
TFX
$5.85B
| $1.1M | ﹤0.01% |
+4,306
| New | +$1.13M |
|
|
WIN
2384
DELISTED
Windstream Holdings Inc
WIN
| $1.1M | ﹤0.01% |
155,552
+12,723
| +9% | +$104K |
|
2385
Ameriprise Financial
AMP
$46.8B
| $1.09M | ﹤0.01% |
7,405
+3,646
| +97% | +$595K |
|
2386
Oaktree Specialty Lending
OCSL
$1.03B
| $1.09M | ﹤0.01% |
86,677
+28,660
| +49% | +$397K |
|
2387
Five Below
FIVE
$11.2B
| $1.09M | ﹤0.01% |
+14,914
| New | +$1M |
|
2388
NovoCure
NVCR
$2.04B
| $1.09M | ﹤0.01% |
50,206
-15,719
| -24% | -$338K |
|
|
ICD
2389
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.09M | ﹤0.01% |
14,458
-88
| -0.6% | -$7.72K |
|
2390
Ionis Pharmaceuticals
IONS
$9.35B
| $1.09M | ﹤0.01% |
24,762
-54,723
| -69% | -$2.78M |
|
2391
FB Financial Corp
FBK
$2.95B
| $1.09M | ﹤0.01% |
26,811
+9,632
| +56% | +$403K |
|
|
ARR
2392
Armour Residential REIT
ARR
$2.02B
| $1.08M | ﹤0.01% |
+9,286
| New | +$1.08M |
|
|
SIR
2393
DELISTED
SELECT INCOME REIT
SIR
| $1.08M | ﹤0.01% |
126,258
+105,417
| +506% | +$963K |
|
2394
PUT
T. Rowe Price
TROW
$25B
| $1.08M | ﹤0.01% |
+10,000
| New | +$1.11M |
|
|
ADXS
2395
DELISTED
Advaxis Inc
ADXS
| $1.08M | ﹤0.01% |
42,567
+14,273
| +50% | +$533K |
|
|
BLUE
2396
DELISTED
bluebird bio
BLUE
| $1.08M | ﹤0.01% |
487
-8,165
| -94% | -$20.8M |
|
2397
Universal Electronics
UEIC
$57.2M
| $1.07M | ﹤0.01% |
20,660
+15,958
| +339% | +$776K |
|
2398
Enova International
ENVA
$5.91B
| $1.07M | ﹤0.01% |
48,687
+2,078
| +4% | +$41.8K |
|
|
CNCE
2399
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.07M | ﹤0.01% |
46,867
-56,550
| -55% | -$1.26M |
|
2400
Natural Gas Services Group
NGS
$470M
| $1.06M | ﹤0.01% |
44,653
-7,185
| -14% | -$192K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.